Immunomodulatory activity of nivolumab in previously treated and untreated metastatic renal cell carcinoma (mRCC): Biomarker-based results from a randomized clinical trial.
Toni K. Choueiri
Consultant or Advisory Role - AVEO; Bayer; GlaxoSmithKline; Novartis; Pfizer
Research Funding - Pfizer
Mayer N. Fishman
Research Funding - Bristol-Myers Squibb
Bernard J. Escudier
Consultant or Advisory Role - Bayer; Novartis; Pfizer
Honoraria - AVEO; Bayer; Genentech; GlaxoSmithKline; Novartis; Pfizer; Roche
Jenny J. Kim
No relevant relationships to disclose
Harriet M. Kluger
No relevant relationships to disclose
Walter Michael Stadler
Research Funding - Bristol-Myers Squibb
Jose Luis Perez-Gracia
Research Funding - Bristol-Myers Squibb
Douglas G. McNeel
No relevant relationships to disclose
Brendan D. Curti
No relevant relationships to disclose
Michael Roger Harrison
Consultant or Advisory Role - AVEO; Exelixis; Novartis
Honoraria - Novartis; Prometheus
Research Funding - Argos Therapeutics; Bristol-Myers Squibb; Exelixis; Pfizer
Elizabeth R. Plimack
Consultant or Advisory Role - GlaxoSmithKline
Research Funding - Acceleron Pharma; Bristol-Myers Squibb; GlaxoSmithKline; Merck
Leonard Joseph Appleman
No relevant relationships to disclose
Lawrence Fong
Research Funding - Bristol-Myers Squibb
Charles G. Drake
Consultant or Advisory Role - Bristol-Myers Squibb; Dendreon; Janssen; Pfizer; Roche
Research Funding - Aduro Biotech; Bristol-Myers Squibb
Lewis J. Cohen
Employment or Leadership Position - Bristol-Myers Squibb
Stock Ownership - Bristol-Myers Squibb
Shivani Srivastava
Employment or Leadership Position - Bristol-Myers Squibb
Stock Ownership - Bristol-Myers Squibb
Maria Jure-Kunkel
Employment or Leadership Position - Bristol-Myers Squibb
Stock Ownership - Bristol-Myers Squibb
Quan Hong
Employment or Leadership Position - Bristol-Myers Squibb
Stock Ownership - Bristol-Myers Squibb
John F. Kurland
Employment or Leadership Position - Bristol-Myers Squibb
Stock Ownership - Bristol-Myers Squibb
Mario Sznol
Consultant or Advisory Role - Amgen; Anaeropharma; Bristol-Myers Squibb; Genentech; MedImmune; Nektar; Symphogen